Aurora Cannabis Inc.

NYSE: ACB
$3.91
+$0.12 (+3.2%)
Closing price January 28, 2022
There may be a new dawn for Aurora Cannabis as online sales rise, new retail outlets open, and Reliva deal offers access to U.S. market.
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
The euphoria that followed the announcement Wednesday that Aurora Cannabis is acquiring Reliva was subsiding Friday.
Friday's top analyst upgrades and downgrades included Agilent Technologies, Aurora Cannabis, Best Buy, Box, Marvell Technology, Nvidia, Palo Alto Networks, Roku, Splunk and TJX Companies.
Aphria stays strong while Green Growth, which tried to buy it, goes bust. Canadian rival Aurora buys U.S. hemp retailer Reliva.
Investors can’t figure out if it’s dawn or dusk for Aurora Cannabis, and that means a wild ride for the stock.
High times in hard times? Tilray says pot should be seen as a consumer staple rather than an indulgence.
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
Canadian pot grower Aurora Cannabis posted a solid beat over analysts' revenue expectations and shares are booming as a result.
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
Chesapeake stock runs out of energy as coronavirus cuts demand for oil faster than producers cut supply.
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
A 12-for-1 reverse stock split by Canada-based pot grower Aurora Cannabis became effective Monday. The change was necessary to maintain the company's listing on the New York Stock Exchange.